Stay updated on Phase 1b Combo w/ Ribociclib & Alpelisib Clinical Trial

Sign up to get notified when there's something new on the Phase 1b Combo w/ Ribociclib & Alpelisib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 1b Combo w/ Ribociclib & Alpelisib Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The site's footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:26:05.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now displayed for the study record, with minimal HTML including a 403 title and a Home link.
    Difference
    20%
    Check dated 2026-09-23T00:38:32.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The page now reflects a status of Active, not recruiting and No longer looking for participants. It also adds the Vanderbilt-Ingram Cancer Center and Kenneth Caldwell, MD as the study site and investigator and expands the study to four treatment groups.
    Difference
    4%
    Check dated 2026-09-15T23:40:59.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6. This appears to be a minor platform update with no apparent changes to study details or page content.
    Difference
    0.0%
    Check dated 2026-09-01T20:29:20.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.6.4 to v3.6.5, indicating a small maintenance update. No user-facing content appears to be changed.
    Difference
    0.0%
    Check dated 2026-08-11T17:00:58.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating a new build of the page rendering. This appears to be a behind-the-scenes update and does not alter the study details.
    Difference
    0.0%
    Check dated 2026-07-28T10:39:25.000Z thumbnail image

Stay in the know with updates to Phase 1b Combo w/ Ribociclib & Alpelisib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 1b Combo w/ Ribociclib & Alpelisib Clinical Trial page.